• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利拉齐奥地区 COVID-19 大流行对多发性硬化症患者获得医疗服务的影响。

Impact of the COVID-19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy.

机构信息

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Department of Health Information Systems, Lazio Regional Health Service, Rome, Italy.

出版信息

Eur J Neurol. 2021 Oct;28(10):3403-3410. doi: 10.1111/ene.14879. Epub 2021 May 14.

DOI:10.1111/ene.14879
PMID:33896086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8250799/
Abstract

BACKGROUND AND PURPOSE

Multiple sclerosis (MS) is a complex chronic, autoimmune inflammatory disease involving multidisciplinary assessments and interventions. Access to outpatient specialist and home healthcare services was explored during the pandemic outbreak and the lockdown amongst MS patients in the Lazio region. Adherence to disease-modifying therapies (DMTs) is also described.

METHODS

A population-based study was conducted using regional healthcare administrative databases. A validated algorithm was used to identify MS cases over the period 2011-2018. The numbers of specialist and home-based services were compared between 2019 and 2020. The medication possession ratio was used to measure adherence to DMTs.

RESULTS

A total of 9380 MS patients were identified (68% women). A decline in the number of outpatient care services between March and June 2020 compared to the previous year was observed, in particular for rehabilitation (-82%), magnetic resonance imaging (-56%) and neurological specialist services (-91%). Important year-to-year variations were observed in May and June 2020 in home-based nursing and medical care (-91%) and motor re-education services (-74%). Adherence to DMTs was higher in the first 4 months of 2019 compared to the same period of 2020 (67.1% vs. 57.0%).

CONCLUSIONS

A notable disruption of rehabilitative therapy and home-based services as well as in DMT adherence was observed. Since the pandemic is still ongoing and interruption of healthcare services could have a major impact on MS patients, it is necessary to monitor access of MS patients to healthcare resources in order to ensure adequate treatments, including rehabilitative therapies.

摘要

背景与目的

多发性硬化症(MS)是一种复杂的慢性自身免疫性炎症性疾病,涉及多学科评估和干预。在大流行爆发期间和封锁期间,探讨了 MS 患者获得门诊专科和家庭保健服务的机会,并描述了他们对疾病修正治疗(DMT)的依从性。

方法

本研究采用区域医疗保健管理数据库进行了一项基于人群的研究。使用验证后的算法在 2011-2018 年期间确定 MS 病例。比较了 2019 年和 2020 年专科和家庭服务的数量。采用药物持有率来衡量 DMT 的依从性。

结果

共确定了 9380 例 MS 患者(68%为女性)。与前一年相比,2020 年 3 月至 6 月期间门诊护理服务数量下降,特别是康复治疗(-82%)、磁共振成像(-56%)和神经科专科服务(-91%)。2020 年 5 月和 6 月,家庭护理和医疗(-91%)以及运动再教育服务(-74%)的年变化较大。与 2020 年同期相比,2019 年的前 4 个月 DMT 依从性更高(67.1% vs. 57.0%)。

结论

我们观察到康复治疗和家庭服务以及 DMT 依从性明显中断。由于大流行仍在继续,中断医疗服务可能对 MS 患者产生重大影响,因此有必要监测 MS 患者获得医疗资源的机会,以确保他们获得足够的治疗,包括康复治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/e0b6e4561162/ENE-28-3403-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/4e9f65f71876/ENE-28-3403-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/4265ae2557e5/ENE-28-3403-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/b2e2e5fae296/ENE-28-3403-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/e0b6e4561162/ENE-28-3403-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/4e9f65f71876/ENE-28-3403-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/4265ae2557e5/ENE-28-3403-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/b2e2e5fae296/ENE-28-3403-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3aa/8250799/e0b6e4561162/ENE-28-3403-g005.jpg

相似文献

1
Impact of the COVID-19 pandemic on access to healthcare services amongst patients with multiple sclerosis in the Lazio region, Italy.意大利拉齐奥地区 COVID-19 大流行对多发性硬化症患者获得医疗服务的影响。
Eur J Neurol. 2021 Oct;28(10):3403-3410. doi: 10.1111/ene.14879. Epub 2021 May 14.
2
Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study.COVID-19 对多发性硬化症患者医疗服务的影响和系统恢复:基于人群的研究。
Neurol Sci. 2023 Nov;44(11):3771-3779. doi: 10.1007/s10072-023-07052-9. Epub 2023 Sep 6.
3
Indirect impact of the COVID-19 pandemic on the care and outcomes of people with MS: A combined survey and insurance claims study.2019冠状病毒病大流行对多发性硬化症患者护理及预后的间接影响:一项综合调查与保险理赔研究
Mult Scler Relat Disord. 2023 Dec;80:105085. doi: 10.1016/j.msard.2023.105085. Epub 2023 Oct 16.
4
How the COVID-19 Pandemic has changed multiple sclerosis clinical practice: Results of a nationwide provider survey.COVID-19 大流行如何改变多发性硬化症的临床实践:全国性提供者调查结果。
Mult Scler Relat Disord. 2021 Jun;51:102913. doi: 10.1016/j.msard.2021.102913. Epub 2021 Mar 18.
5
Understanding and managing the impact of the Covid-19 pandemic and lockdown on patients with multiple sclerosis.了解和管理新冠疫情和封锁对多发性硬化症患者的影响。
Expert Rev Neurother. 2021 Jul;21(7):731-743. doi: 10.1080/14737175.2021.1957673. Epub 2021 Jul 24.
6
Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies.多发性硬化症和 COVID-19:评估风险认知、患者行为和获得疾病修正治疗的机会。
Mult Scler Relat Disord. 2022 Dec;68:104121. doi: 10.1016/j.msard.2022.104121. Epub 2022 Aug 17.
7
Risk of Getting COVID-19 in People With Multiple Sclerosis: A Case-Control Study.多发性硬化症患者感染 COVID-19 的风险:一项病例对照研究。
Neurol Neuroimmunol Neuroinflamm. 2022 Jan 19;9(2). doi: 10.1212/NXI.0000000000001141. Print 2022 Mar.
8
Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England.大规模疫苗接种对英国使用免疫调节疾病修正疗法的多发性硬化症患者中 SARS-CoV-2 感染的影响。
Mult Scler Relat Disord. 2022 Jan;57:103458. doi: 10.1016/j.msard.2021.103458. Epub 2021 Dec 5.
9
Multiple sclerosis management during the COVID-19 pandemic.COVID-19 大流行期间的多发性硬化症管理。
Mult Scler. 2020 Sep;26(10):1163-1171. doi: 10.1177/1352458520948231. Epub 2020 Aug 10.
10
Impact of Covid-19 emergency on rehabilitation services for Multiple Sclerosis: An international RIMS survey.Covid-19 紧急情况对多发性硬化症康复服务的影响:一项国际 RIMS 调查。
Mult Scler Relat Disord. 2022 Nov;67:104179. doi: 10.1016/j.msard.2022.104179. Epub 2022 Sep 15.

引用本文的文献

1
Impact of the COVID-19 Lockdown on Inhaler Adherence in Patients with COPD: A South Korean Nationwide Cohort Study.新冠疫情封锁对慢性阻塞性肺疾病患者吸入器依从性的影响:一项韩国全国性队列研究
Healthcare (Basel). 2025 Jun 15;13(12):1431. doi: 10.3390/healthcare13121431.
2
Patient Perspectives on Healthcare Utilization During the COVID-19 Pandemic in People with Multiple Sclerosis-A Longitudinal Analysis.多发性硬化症患者在新冠疫情期间对医疗保健利用的看法——一项纵向分析
Healthcare (Basel). 2025 Mar 16;13(6):646. doi: 10.3390/healthcare13060646.
3
COVID-19 and multiple sclerosis: challenges and lessons for patient care.

本文引用的文献

1
Impact of the COVID-19 pandemic on persons with multiple sclerosis: Early findings from a survey on disruptions in care and self-reported outcomes.COVID-19 大流行对多发性硬化症患者的影响:一项关于护理中断和自我报告结果的调查的早期发现。
J Health Serv Res Policy. 2021 Jul;26(3):189-197. doi: 10.1177/1355819620975069. Epub 2020 Dec 18.
2
The impact of COVID-19 on chronic care according to providers: a qualitative study among primary care practices in Belgium.COVID-19 对慢性病护理的影响:比利时初级保健实践中的一项定性研究。
BMC Fam Pract. 2020 Dec 5;21(1):255. doi: 10.1186/s12875-020-01326-3.
3
Impact of COVID-19 on people with physical disabilities: A rapid review.
2019冠状病毒病与多发性硬化症:患者护理面临的挑战与经验教训
Lancet Reg Health Eur. 2024 Aug 22;44:100979. doi: 10.1016/j.lanepe.2024.100979. eCollection 2024 Sep.
4
Analysis on the epidemiological and drug resistance characteristics of osteoarticular tuberculosis in South-central China.中国中南部骨关节结核的流行病学及耐药特征分析
Front Public Health. 2024 Aug 30;12:1432071. doi: 10.3389/fpubh.2024.1432071. eCollection 2024.
5
Impact of COVID-19 and system recovery in delivering healthcare to people with multiple sclerosis: a population-based Study.COVID-19 对多发性硬化症患者医疗服务的影响和系统恢复:基于人群的研究。
Neurol Sci. 2023 Nov;44(11):3771-3779. doi: 10.1007/s10072-023-07052-9. Epub 2023 Sep 6.
6
COVID-19 and the Pandemic-Related Aspects in Pediatric Demyelinating Disorders.COVID-19 与儿科脱髓鞘疾病相关的大流行方面。
Semin Pediatr Neurol. 2023 Jul;46:101055. doi: 10.1016/j.spen.2023.101055. Epub 2023 May 10.
7
COVID-19 and Health Outcomes in People with Multiple Sclerosis: A Population-Based Study in Italy.多发性硬化症患者的 COVID-19 与健康结局:意大利一项基于人群的研究
Life (Basel). 2023 Apr 27;13(5):1089. doi: 10.3390/life13051089.
8
Occurrence and Severity of Coronavirus Disease 2019 Are Associated With Clinical Disability Worsening in Patients With Multiple Sclerosis.新冠肺炎的发生和严重程度与多发性硬化症患者的临床残疾恶化有关。
Neurol Neuroimmunol Neuroinflamm. 2023 Feb 17;10(3). doi: 10.1212/NXI.0000000000200089. Print 2023 May.
9
Exploring COVID-19 experiences for persons with multiple sclerosis and carers: An Australian qualitative study.探索 COVID-19 对多发性硬化症患者及其照顾者的影响:一项澳大利亚定性研究。
Health Expect. 2023 Apr;26(2):785-794. doi: 10.1111/hex.13704. Epub 2023 Jan 13.
10
The Impact of COVID-19 Lockdown Restrictions on Exercise Behavior Among People With Multiple Sclerosis Enrolled in an Exercise Trial: Qualitative Interview Study.2019年冠状病毒病封锁限制对参加运动试验的多发性硬化症患者运动行为的影响:定性访谈研究
JMIR Rehabil Assist Technol. 2022 Nov 22;9(4):e42157. doi: 10.2196/42157.
新冠疫情对肢体残疾人士的影响:快速综述。
Disabil Health J. 2021 Jan;14(1):101014. doi: 10.1016/j.dhjo.2020.101014. Epub 2020 Nov 1.
4
Impact of disease-modifying drugs on the severity of  COVID-19 infection in multiple sclerosis patients.疾病修正药物对多发性硬化症患者 COVID-19 感染严重程度的影响。
J Med Virol. 2021 Mar;93(3):1314-1319. doi: 10.1002/jmv.26593. Epub 2020 Oct 30.
5
Multiple sclerosis and COVID-19: How many are at risk?多发性硬化症与 COVID-19:有多少人面临风险?
Eur J Neurol. 2021 Oct;28(10):3369-3374. doi: 10.1111/ene.14555. Epub 2020 Oct 22.
6
Impact of the COVID-19 pandemic on the health care of >1,000 People living with multiple sclerosis: A cross-sectional study.COVID-19 大流行对 1000 多名多发性硬化症患者的医疗保健的影响:一项横断面研究。
Mult Scler Relat Disord. 2020 Nov;46:102512. doi: 10.1016/j.msard.2020.102512. Epub 2020 Sep 19.
7
COVID-19 and Multiple Sclerosis: Predisposition and Precautions in Treatment.新型冠状病毒肺炎与多发性硬化症:治疗中的易感性与预防措施
SN Compr Clin Med. 2020;2(10):1802-1807. doi: 10.1007/s42399-020-00504-9. Epub 2020 Sep 3.
8
Disease-Modifying Therapies During the COVID-19 Outbreak: A Narrative Review of International and National Recommendations.新冠疫情期间的疾病修正疗法:国际和国内建议的叙述性综述
Int J MS Care. 2020 Jul-Aug;22(4):151-157. doi: 10.7224/1537-2073.2020-037. Epub 2020 May 18.
9
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.多发性硬化症的疾病修正治疗与 COVID-19 大流行:感染风险和未来疫苗接种的影响。
CNS Drugs. 2020 Sep;34(9):879-896. doi: 10.1007/s40263-020-00756-y.
10
Multiple sclerosis management during the COVID-19 pandemic.COVID-19 大流行期间的多发性硬化症管理。
Mult Scler. 2020 Sep;26(10):1163-1171. doi: 10.1177/1352458520948231. Epub 2020 Aug 10.